Vancouver, B.C. – Acuitas Therapeutics, the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, recently announced that the company’s partner, AstraZeneca, has published a new study… Read More
WELLSTAR has completed the acquisition of two medical billing assets: PatientSERV is Ontario’s leading uninsured and third‑party medical billing platform; Lambert Médico Factures is one of Québec’s most established medical billing… Read More
Researchers at the UBC Faculty of Medicine are advancing a transformative new approach to sports and human performance monitoring through collaborative research funded by Samsung Electronics Canada. The new project… Read More
For the first time, Eupraxia is reporting 24-week data on symptom response from the highest dose cohort in the open label, Phase 1b/2a portion of the RESOLVE trial. The data… Read More
Reverb Therapeutics is a next-generation biotechnology company on a mission to harness the body’s own immune signals — cytokines — to develop safer, more precise treatments for cancer and autoimmune… Read More
